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Introduction: Depression is one of the most common
mental health disorders that may affect women during
pregnancy. The prompt identification of this disorder, and
the provision of treatment, may help to reduce the
likelihood of post-partum depression, prevent severe
forms of the disease, and reduce its intergenerational
impact. Despite women’s repeated encounters with health
services throughout their antenatal care, depression often
goes undiagnosed. This is one area where mobile health
could prove useful. We will assess the feasibility of using
tablets to incorporate depression screening into antenatal
pathways. We will also assess if survey layout could affect
the quality of the data collected through these devices.
Methods and analysis:We will test the feasibility of
using iPad Airs for the administration of the Whooley
questions and the Edinburgh Postnatal Depression Scale
(EPDS) to pregnant women attending antenatal clinics in
England. We will assess the impact of survey layout on
the quality of the responses given to these screening
scales using a parallel, randomised controlled study
design. We will calculate the positive predictive value, the
negative predictive value and the false omission rate of
the Whooley questions in comparison with the EPDS. We
will calculate differences in data equivalence, time needed
to complete the surveys, break-off rates, data
completeness and requests for help between the 2
experimental groups: using all questions in one screen
and navigation by vertical scrolling, or a single question
per screen and navigation by multiple pages.
Ethics and dissemination: This study has been
approved by the National Research Ethics Service
Committee South East Coast—Surrey. Our findings will
be disseminated through academic peer-reviewed
publications, conferences and discussion with peers.
INTRODUCTION
Maternal mental health is a key public health
priority due to the impact it can have on a
woman’s well-being and on her child’s emo-
tional, behavioural, cognitive and social
development.1–5 Perinatal depression is one
of the most common psychiatric disorders
that can affect up to 15% of women during
pregnancy or within 1 year of giving birth.
The direct and indirect ﬁnancial costs of
perinatal depression to the health system,
together with its direct impact on the
mother and her child, account for the major-
ity of the overall costs to society of perinatal
mental disorders.5 In the UK, these costs
have been estimated at £8.1 billion for each
1-year cohort of birth (with the average costs
of one case of perinatal depression estimated
at £74 k), 72% of which could be attributed
to the adverse effects experienced by the
child.2 For this reason, the early identiﬁca-
tion of women who might be at risk of
Strengths and limitations of this study
▪ This study addresses an important area of unmet
clinical need, which has a considerable impact
on healthcare systems and society in general.
▪ This study will attempt to identify implementa-
tion issues (arising from the introduction of an
mHealth intervention into a clinical process) that
could impair the ability of already busy health-
care professionals to perform their clinical
duties. This is in contrast to some existing
studies, where mHealth interventions are
deployed in highly controlled environments that
do not capture the realities of clinical settings.
▪ This study will explore the effect that survey
presentation could have on the quality of the
data collected (when using a validated scale).
This is in contrast to other studies in the medical
literature (that assess mHealth interventions),
which have not explored how these additional
factors could affect data quality.
▪ This study will explore mHealth as a delivery
mode for a depression screening validated scale.
However, it will not evaluate the potential of
mHealth as a delivery mode for evidence-based
interventions.
▪ Our findings might only be generalisable to
devices with similar technical specifications that
are being used in similar clinical settings.
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developing or have perinatal depression should be con-
sidered a priority.6
Women appear to be at an increased risk of depression
3–6 months after childbirth,1 4 although a recent longitu-
dinal study found that symptoms of depression may be
more prevalent at 4 years post-partum.7 Several factors
are known to increase the likelihood of developing post-
partum depression.1 6 8 Depression during pregnancy,
however, has been recognised as one of the most import-
ant risk factors and one that is susceptible to early inter-
vention. The point prevalence of depression during the
ﬁrst, second and third trimesters of pregnancy has been
estimated at 7.4%, 12.8% and 12%, respectively.9 The
timely identiﬁcation of depression during these stages,
and the provision of appropriate treatment, can reduce
the likelihood of developing post-partum depression,
prevent more severe forms of this disorder, and improve
a woman’s general health status.4 5 Treating depression
during pregnancy may also help reduce the intergenera-
tional impact of this condition.
Nonetheless, depression during pregnancy often goes
undiagnosed and its routine screening is still debated.10
Validated screening tools, such as the Edinburgh
Postnatal Depression Scale (EPDS), can facilitate the
early identiﬁcation of depressive symptoms in pregnant
women.11 However, cost-effectiveness is often cited as one
of the key reasons against the routine screening for this
condition.12 This is an area where smartphones and
tablet computers could demonstrate their value in a ﬁeld
of study that is known as mobile health (mHealth).
Thanks to their advanced computational and networking
capabilities, and overall popularity (in the ﬁrst quarter of
2015, it was reported that approximately 66% of adults in
the UK owned a smartphone),13 these devices could facili-
tate depression screening and monitoring of symptoms14
while reducing costs and administrative burden.
Researchers from the School of Social Work at the
University of Illinois and staff members at
Champaign-Urbanara Public Health District will be
testing the use of tablet computers to implement depres-
sion screening in maternal clinics.15 They will be doing
so during antenatal consultations. Mobile devices could
be used to screen for depression before a consultation,
thus releasing some of the consultation time. For this
reason, we need to establish the feasibility of using these
devices to do so.
One aspect of delivering depression screening
through mobile devices is the impact that this technol-
ogy may have on data quality. This is to ensure that the
data accurately reﬂect underlying clinical changes. Our
recent Cochrane review16 suggests that collecting patient
self-reported data through apps is equivalent to collect-
ing data through alternative delivery modes (ie, paper,
short messaging service, laptops, plastic rulers and per-
sonal digital assistants). This review also highlighted that
equivalence, and other data quality dimensions, could
be affected by factors other than the delivery mode.16
One such factor is survey presentation. Unlike the survey
methodology literature, however,17 18 the effect of this
factor on validated clinical tools has not been systematic-
ally explored in the medical literature.
In this study, we will assess the feasibility of implement-
ing the recommendations from The National Institute
for Health and Care Excellence (NICE)19 for recognising
depression during pregnancy. We will conduct our study
in the waiting area of general practices, community mid-
wiferies and hospitals using iPad Air tablets. We will evalu-
ate the statistical properties of one of the validated
instruments recommended by this guideline. We will also
assess if survey layout (as a component of survey presenta-
tion) affects the quality of the responses collected
through the screening instruments under evaluation.
METHODS AND ANALYSIS
Study design
We will assess the feasibility of using iPad Air tablets to
administer a brief survey asking for personal information,
the Whooley questions and the EPDS (see online supple-
mentary appendix 1) to pregnant women attending ante-
natal clinics across a number of primary and secondary
care National Health Service (NHS) centres in England.
iPad Air tablets have a 9.7-inch (diagonal) retina display,
with a 2048-by-1536 resolution at 264 pixels per inch.
Study data will be collected and managed using Snap
survey tools.20 Snap Mobile app V.4.0.30 (or later, if a new
version becomes available) will be running on iOS V.9.0.2
(or later, if a new version becomes available).
In order to evaluate the effect of survey layout on data
quality, we will use a parallel, randomised controlled
study design. Pregnant women consenting to take part
in this study will be randomly assigned to complete (1)
an app version of the Whooley questions and the EPDS
in which all the questions are presented on a single
screen (app screening—scrolling layout), causing partici-
pants to scroll vertically on the device; or (2) an app
version of the Whooley questions and the EPDS in
which only one question per page is presented at any
given time (app screening—paging layout), causing par-
ticipants to navigate through multiple pages.
Pilot phase
We piloted both versions of the surveys used in this study
(paging layout and scrolling layout) with four staff
members at the Department of Primary Care and Public
Health at Imperial College London. This phase allowed
us to identify (and rectify) the following issues:
▸ Font size;
▸ Consistency of response formats (in particular,
observed differences between yes–no questions and
multiple choice questions with a single answer);
▸ Framing of the survey results.
Sample selection and recruitment
We will select our sample of participants from pregnant
women attending antenatal clinics in general practices,
2 Marcano-Belisario JS, et al. BMJ Open 2016;6:e009930. doi:10.1136/bmjopen-2015-009930
Open Access
group.bmj.com on January 29, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
midwifery services and hospitals ,which are part of the
NHS in England. Each potential participant will be
assessed by clinical staff against our inclusion and exclu-
sion criteria (table 1).
On the day in the antenatal clinic, potential partici-
pants will be ﬁrst approached in the waiting room of the
participating centres by a member of the clinical care
team. If a potential participant expresses her interest in
this study, she will be introduced to one of our research-
ers who will explain the details of the study to her.
Potential participants will be provided with a patient
information sheet. The researcher will emphasise that
the potential participant can ask any questions regarding
the study. If a potential participant agrees to take part in
this study, she will be asked to complete a consent form,
followed by the study procedures (ie, personal demo-
graphic survey, Whooley questions, and Edinburgh
Postnatal Depression Scale). Otherwise, if she is unsure
about participation, she will have at least 24 h to decide.
In this case, she would only take part in the study if she
comes into contact with the research team during a
future antenatal clinic.
Refusal to take part in this study will not have an
impact on a woman’s legal rights, medical care or on
the relationship with her care providers. We will obtain
written, informed consent from those women who, after
receiving all the relevant study information and asking
study-related questions, still wish to take part in this
study.
Interventions to be measured
Surveys
Non-validated, personal demographic survey
We will administer an 11-question survey to collect infor-
mation about the woman’s age group, ethnic back-
ground, marital status, employment status, level of
education, smartphone or tablet computer ownership,
parity, and previous personal history of depression.
Whooley questions
The Whooley questions were developed as a case-ﬁnding
instrument for depression in primary care.22 This two-
question instrument assesses depressed mood and anhe-
donia that have been present during the past month.
Respondents are required to answer yes or no to each
question.
Edinburgh Postnatal Depression Scale
The EPDS is a 10-item self-administered survey that was
developed to screen for perinatal depression in the com-
munity.23 This instrument assesses feelings of guilt, sleep
disturbance, reduced energy levels, anhedonia and sui-
cidal ideation that have been present during the past
7 days. Each question is scored on a four-point scale
ranging from 0 to 3 points. An overall score is calculated
by adding the scores from each individual question.
Overall scores between 10 and 12 points suggest
increased risk for depression; scores of 13 points or
more suggest that the diagnostic criteria for major
depression disorder have probably been met.24 In add-
ition, special attention should be paid to item 10, as it
deals with suicidal thoughts. On the basis of these
scores, a clinician would be prompted to refer a woman
to a mental health professional.
The EPDS is a valid and reliable tool for identifying
women who are at risk of depression, both during preg-
nancy and post-partum. This instrument is also sensitive
to changes in the severity of depression over time.23 The
EPDS can be reproduced without further permission
provided that the original source of the scale is cited in
each reproduced copy.
Screening for depression and effect of survey layout
Pregnant women taking part in our study will receive
verbal instructions on how to complete the surveys.
Participants will also be informed that we will communi-
cate their answers to the Whooley questions and their
scores on the EPDS to their clinicians, and that these
results will be available for discussion during their ante-
natal appointment. Participants’ results on the Whooley
questions and on the EPDS will be communicated to
their general practitioners.
The researcher will also explain to participants that
they can ask for help at any point while completing the
surveys, and that all questions should be directed to a
member of the research team (not to the clinical care
team). We will offer help with the use of the device.
However, we will not offer help reading questions out
loud to participants (as the Whooley questions and the
EPDS are intended to be used as self-administered
instruments).
Participants will be asked to complete all the surveys
while waiting for their appointment in the waiting room
of participating NHS sites. They will be randomised to
one of two experimental manipulations of the survey
layout.
Table 1 Participant inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Women who are 18 years
old or older
Current diagnosis of mood
(affective) disorders as
specified in the ICD-10,
Classification of Mental Health
and Behavioural Disorders21
Pregnant and of any
gestational age
Currently receiving treatment
for mood (affective) disorders
Any parity Recent personal history of
mood (affective) disorders
within the past 12 months
Attending antenatal clinics
in participating NHS sites
Not comfortable reading and
writing in English
ICD-10, 10th revision of the International Statistical Classification
of Disease and Related Health Problems; NHS, National Health
Service.
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Scrolling layout
In this experimental manipulation, all the surveys will be
presented on a single screen (ﬁgure 1). Therefore, par-
ticipants will need to scroll vertically in order to answer
all the questions. They will be able to scroll up and
down as they wish and to modify the answers given to
previous questions as long as they do it before submit-
ting their answers. Once a participant has submitted her
answers, a message acknowledging their participation
will be displayed on the screen of the device and they
will no longer be able to modify their answers. Once all
the surveys have been completed, participants will be
asked to return the iPad Air to a member of the
research team. Validation procedures built into Snap
surveys will ensure that participants are not able to
submit unanswered questions.
Paging layout
In this experimental manipulation, participants will only
see one question on the screen at any given time
(ﬁgure 2). They will need to select and submit their
answer to the current question before being able to
move on to the next question. Participants will not be
allowed to revisit already answered questions. Once a
participant has submitted all her answers, a message
acknowledging her participation will be displayed on the
screen of the device. Once all the surveys have been
completed, participants will be asked to return the iPad
Air to a member of the research team. Validation proce-
dures built into Snap surveys will ensure that participants
are not able to submit unanswered questions.
Randomisation
We will utilise a block randomisation procedure to allo-
cate participants to one of the two experimental arms.
Random numbers will be generated using Stata V.13.0
(Stata. Stata Statistical Software[Program]. Version 13,
2013). Each consecutive number that is generated will
be printed and put inside an opaque envelope, which
will then be sealed. Envelopes will be numbered in an
ascending sequence. Once a participant has provided
informed consent, the researcher will take the relevant
envelope, open it and use the number contained in it to
allocate the participant to one of the two experimental
groups. Researchers conducting participant recruitment
will not be involved in this randomisation procedure in
order to avoid recruitment bias.
Outcomes
Positive predictive value of the Whooley questions
We will calculate the number of pregnant women who
answered yes to any of the Whooley questions AND who
scored 10 points or higher on the EPDS, as a proportion
of the total number of pregnant women who answered
yes to any of the Whooley questions regardless of their
EPDS scores.
Negative predictive value of the Whooley questions
We will calculate the number of pregnant women who
answered no to both Whooley questions AND who
scored nine points or less on the EPDS, as a proportion
of the total number of pregnant women who answered
no to both Whooley questions regardless of their EPDS
scores.
False omission rate of the Whooley questions
We will calculate the number of pregnant women who
answered no to both Whooley questions AND who
scored 10 points or higher on the EPDS, as a proportion
of the total number of pregnant women who answered
no to both Whooley questions regardless of their EPDS
scores.
Mean overall scores on the EPDS
For each experimental group, we will sum the individual
scores on the EPDS and divide the total by the number
of participants in the group. We will also calculate the
mean overall scores on the EPDS for our total sample.
Break-off rates
We will calculate the proportion of participants who
interrupt the survey before reaching the end. In such
eventualities, we will document the reason for the
break-off.
Time needed to complete surveys
We will measure the time in seconds between a partici-
pant starting to read the basic instructions on how to
complete the survey and the participants receiving the
message acknowledging their participation. We will also
account for the time that participants spend experien-
cing problems, distractions or making requests for help
or clariﬁcation.
Proportion of complete EPDS records
We will deﬁne a complete record as one in which no
question was left unanswered. Leaving unanswered ques-
tions will not be possible due to the implementation of
data validation procedures. Therefore, data complete-
ness will be a by-product of break-off rates.
Proportion of participants requesting help
We will document the requests for help made by our
participant. We will categorise participants into three
groups: (1) one request for help; (2) between two and
four requests for help; and (3) ﬁve or more requests for
help. We will compute the proportion of participants
falling within each category.
Proportion of each type of request for help
We will document the reasons for each request for help.
This information will be captured through a post study
procedures survey that researchers will have to complete.
We will conduct a content analysis of these requests in
order to categorise them according to their nature.
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Sample size calculations
We powered our study according to the positive predict-
ive value (PPV), negative predictive value (NPV) and
false omission rate (FOR) of the Whooley questions. In
order to calculate these outcomes, we would need at
least 30 events (deﬁned as pregnant women scoring 10
points or more on the EPDS). Assuming a prevalence of
depression in pregnant women of 12%, we would need
to recruit 250 participants in our study. We decided to
recruit a total of 300 participants to account for any
eventualities, such as dropouts.
Data analysis plan
Descriptive statistics
We will report the number of participants approached
who did not meet our inclusion criteria, as well as the
reason for exclusion. We will also report the number of
participants who refused to take part in our study as a
proportion of the total number of participants who were
initially approached.
We will report the following information for each
experimental group:
▸ Demographic characteristics (as captured by our non-
validated survey);
▸ Proportion of participants answering Yes to any of the
Whooley questions;
▸ Proportion of participants scoring at each interval of
the EPDS: between 0 and 9 points; between 10 and
12 points; and 13 points or above;
▸ Proportion of participants scoring 2 or 3 points on
question 10 of the EPDS;
▸ Mean time taken to complete the surveys;
Figure 1 Scrolling layout
(screenshot).
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▸ Proportion of participants making requests for help;
▸ Proportion of participants making each type of
request;
▸ Mean time spent dealing with requests for help; and
▸ Break-off rates and reasons for break-off.
Inferential statistics
PPV, NPV and FOR
We will calculate the PPV, NPV and FOR of the Whooley
questions for the total sample of participants, and will
report these values as percentages. We will also test for
signiﬁcant differences between the two experimental
groups in these outcomes using a t test.
Data equivalence
We will determine data equivalence between the experi-
mental groups (scrolling and paging) by testing for stat-
istically signiﬁcant differences in the mean overall scores
on the EPDS. For this, we will conduct a t test. In add-
ition, we will compare the proportion of women scoring
(1) between 10 and 12 points, and (2) 13 points or
more on the EPDS between the two experimental
groups using a t test.
Time needed to complete surveys
We will compare the mean time needed by participants
to complete the survey questionnaire between the
experimental groups using a t test.
Data completeness
We will compare the proportion of complete records
between the experimental groups using a t test.
Proportion of requests for help
We will compare the proportion of participants making
requests for help between the experimental groups. For
this, we will conduct a t test for each category in this end
point: (1) one request; (2) between two and four
requests; and (3) ﬁve or more requests.
Timeline
We expect recruitment of participants to take place
between October 2015 and the end of February 2016.
CONCLUSION
We believe that this study addresses an important area of
unmet clinical need which has a direct and indirect
impact on health systems and society. It will also contrib-
ute to building the evidence base for mHealth, particu-
larly when applied to mental health. Unlike other
studies in the medical literature, this study will evaluate
how survey layout could affect the quality of the
responses collected using a validated scale. Evaluating
how different factors could affect data quality becomes
important when data are used to inform clinical and
therapeutic decisions. In addition, this study will also
evaluate some of the implementation issues that might
arise when deploying an mHealth intervention, and that
could affect its successful adoption.
The technical speciﬁcations of a device, such as
screen size, could inﬂuence user interaction and thus
the quality of responses. In addition, usage patterns (in
terms of the type of interactions, duration and frequency
of an interaction, and the type of activities that occur
during an interaction) vary depending on the type of
device and the setting in which it is being used. For
these reasons, our ﬁndings might only be generalisable
to iPad Air tablets (or devices with similar technical spe-
ciﬁcations) that are being used in clinical settings.
Therefore, in a future study, we will explore issues asso-
ciated with the at-home collection of mood data during
pregnancy, using participants’ own devices.
The ﬁndings from this feasibility study will inform a
larger trial evaluating the integration of this intervention
into routine antenatal pathways, and the potential
impact on clinical outcomes.
ETHICS AND DISSEMINATION
This study has been reviewed and approved by the
National Research Ethics Service (NRES) Committee
South East Coast—Surrey on 9 July 2015 under the
Figure 2 Paging layout
(screenshot).
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Research Ethics Committee (REC) reference 15/LO/
0977.
This study is being sponsored by Imperial College
London under the reference number 15IC2687 and has
been included in the UK Clinical Research Network
(CRN) Study Portfolio under the UKCRNID number
19280.
Lastly, this study protocol has been registered in
ClinicalTrials.gov under the identiﬁer NCT02516982 (as
required by the REC).
The ﬁndings of this study will be disseminated
through academic peer-reviewed publications, poster
presentations and abstracts at academic and professional
conferences, discussion with peers, social media and the
Global eHealth Unit website. The ﬁndings of this study
will also inform JSM-B’s PhD thesis.
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